Objective To investigate the diagnostic value of brain magnetic resonance imaging in detecting central nervous system diseases among AIDS patients of different levels of T cells. Methods Total of 164 AIDS patients who did not receive antiviral treatment were divided into 2 groups according to their baseline CD4 + T cell counts. Group A had CD4 + T cell below or equal to 50 cells/μl (n = 81) and group B had CD4 + T cells over 50 cells/μl (n = 83). All patients underwent brain MRI scan. Imaging analysis and the prevalence of the central nervous system disorders were compared between two groups. Results Among them 48 cases were found of abnormal brain MRI, group A was higher than group B (35.8% vs. 22.9%) although without statistical significance (P = 0.065). Altogether 48 cases were diagnosed as AIDS related central nervous system disorders based on clinical symptoms, signs and laboratory findings. The prevalence of CNS disorders was higher in group A than in group B (41.9% vs. 16.8%) with statistical significance (P < 0.01).
P atients with advanced AIDS have a high risk of intracranial opportunistic infections and neoplasms. 1, 2 An autopsy report showed that up to 90% of HIV infected individuals had histopathological changes in the central nervous system (CNS). 3 Although the introduction of HAART led to a decrease of central nervous system opportunistic infections, the prevalence of HIVassociated neurocognitive disorder (HAND) is still on the rise. 4 Thus, early diagnosis of these diseases is important for the clinical management of AIDS patients. Brain magnetic resonance imaging (MRI) is more sensitive to reveal subtle white matter and meningeal abnormalities than computer tomography Shenzhen Third People's Hospital, Shenzhen, 518112, China； Correspondence: Hui Wang, Email: huiwang98@yahoo.com (CT) 5, 6 and has high diagnostic value in the CNS disorders. However, there are few studies on the utility of brain MRI screening to detect intracranial diseases of Chinese AIDS patients, especially for the diagnosis of HAND. This observational study was designed to elavulate the usefulness of brain MRI in screening CNS diseases among advanced AIDS patients with low CD4 + T cell count. Statistical analysis D a t a w e r e a n a l y z e d u s i n g S P S S . B a s e l i n e characteristics between two groups were compared using the Student's t test and chi-square (χ 2 ) for continuous and categorical variable, respectively. Prevalence of abnormal MRI and intracranial disorders was calculated and compared in two groups with the χ 2 test. P value < 0.05 was considered significant. There was no statistical significant difference in median age and sex (P = 0.95, P = 0.33) between two groups ( Table 1) .
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Study design and participants
RESULtS the general information of patients
Prevalence of the abnormal MRi
All study patients have undergone brain MRI scan and the MRI diagnosis were fulfilled by more than two experienced radiologist. Among the 164 study patients, prevalence of the abnormal MRI was 29.2% (n = 48), Abnormality in 29 of 81 from group A (35.8%) was higher than 19 of 83 from group B (22.9%), but there was no statistically significant difference (P = 0.065). Subgroup analysis the type of abnormal MRI, brain atrophy is the most popular type in 26 of 48 abnormal scan (53%). The prevalence of brain atrophy in group A was still higher than group B (21% vs. 10.8%), but the difference was not significant (P = 0.075). The other types of abnormal MR image (n = 37) included lacunar cerebral infarction (n = 10), one or more round spots (n = 6), multiple flake spots (n = 15), confluent lesion (n = 4), structural distortions (n = 2). In addition,some scans showed more than one type of abnormality. For example, 15 other type abnormal MRI scans were found in combination with brain atrophy ( Table 2) .
Prevalence of the central nervous system disorders in the patients
Based on the patient clinical signs and symptoms, laboratory finding, neuroimaging and outcome of diagnostic treatment, 48 of 164 patients were diagnosis of CNS disorder with a prevalence of 29.3%. The cases included HIV-1 associated neurocognitive disorders (n = 19), toxoplasmic encephalitis (n = 6), cryptococcal meningitis (n = 6)，tuberculous meningitis and encephalitis (n = 3), neurosyphilis (n =3), fungal meningitis (n = 1), cerebral infarction (n = 4), PML (n = 2), CNS lymphoma (n = 2), unknown (n = 2). The prevalence of CNS diseases in patients of group A was 41.9% (34/81) and 16.8% (14/83) in patients of group B. The CNS diseases, including HAND and other intracranial diseases, were more prevalent in patients with low CD4 cells than in patients with high CD4 + T cells (P < 0.01) ( Table 3) .
DiSCUSSiON
A growing clinical application of antiviral drugs has greatly reduced medical morbidity and mortality of AIDS patients. 9 However, many patients who were unaware of their HIV status had already been in advanced AIDS. A variety of opportunistic infections, especially intracranial diseases make the diagnosis complex and the mortality rate high. The prevalence (29.3%) of the CNS diseases in our study is higher than most of previous studies in China (10-20%), 10, 11 possibly because of the difference of the study samples. The patients in our study were newly admitted in hospital without ART treatment. Most of their CD4 + T cell counts were less than 200/μl (the median is 51.5/μl) and about half were less than 50/μl.The patients with CD4 + T count < 200/μl had been reported to be a high risk to intracranial diseases. 1 The prevalence (32%) of patients with CD4 + T count < 200/μl in the study in Japanese by Nishijima et al 12 is similar to our result.
Additionally, HIV is a neurotropic virus which invades the central nervous system (CNS) through infecting monocytes and macrophages from the time of primary infection and causes a variety of neurologic dysfunctions and neurocognitive impairments generally termed HAND. 13 It has been estimated that neurocognitive impairment occurred in 20% to 50% of all individuals infected with HIV. [14] [15] [16] [17] In the early HAND, patients may not have any clinical symptoms, or mild impairment of cognitive function.The diagnosis of HAND is based on using combination of neuropsychological tests, brain MRI features and tests on CSF. In this study, the prevalence of HAND is 11.6%, which is similar to the study by Nishijima et al 12 , but is lower than most related studies. There are several possible causes. First, many early HAND patients without obviously clinical symptoms and signs could be ruled out because brain MRI scanning is expensive and physician in charge made selection bias. Second, a part of HAND patients who developed intracranial opportunistic infections were ruled out. Third, the HAART era model of lower frequencies of HIV-associated dementia and increased prevalence of milder forms of HAND is not suitable for our study, in which the all study subjects were HAART naïve and in advanced AIDS. Despite this, HAND was still the most main type of AIDS related CNS diseases (19/48, 39.6%) in our study. HAND has posted an important challenge to the fight agaist AIDS. Early diagnosis of HAND has posted an important challenge against AIDS. MRI has a high sensitivity in identifying lesions of the central nervous system. Brain MRI features in HIV/AIDS patients usually demonstrate widened cortical sulci, enlarged ventricles, reduced gyri, the low signal in T1WI and the high signal in T2WI, the lesion around ventricles and absence of space occupying lesion and strengthening signal. [18] [19] [20] Our results showed that Our study is limited in several ways. Firstly, some AIDS hospitalized patients without HAART can't enter the observation due to the lack of brain MRI examination, especially those in critically ill patients or patients without neurological symptom. Secondly, other clinical profiles including drug addiction, alcoholism, HCV infection, anemia, malnutrition and other factors may affect the brain function were incomplete. Thirdly, the number of study patients is slightly less, which caused difference in the incidence of MRI abnormalities between two groups fail to reach the statistical standard although close to.
In conclusion, AIDS related CNS diseases have a devastating effect on HIV-positive individuals, especially those in whom diagnosis is delayed or concurrent infection with more than one CNS disease. Mortality is often high and thus early detection of HIV and associated CNS diseases is urgent. Magnetic resonance also plays an important role in the diagnosis and differentiation of primary and secondary CNS diseases in advanced AIDS patients and we suggest patients with low CD4 + T cell count (less than 50/μl) should routinely undergo MRI scan even though they have no neurological signs and symptoms. 
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